In the BioHarmony Drug Report Database
Dinoprostone
Cervidil, Prepidil, Prostin E (dinoprostone) is a small molecule pharmaceutical. Dinoprostone was first approved as Cervidil on 1982-01-01. It is used to treat fetal death, gestational trophoblastic disease, and uterine neoplasms in the USA. It is known to target prostaglandin E2 receptor EP4 subtype, solute carrier organic anion transporter family member 2A1, solute carrier organic anion transporter family member 3A1, prostaglandin E2 receptor EP2 subtype, prostaglandin E2 receptor EP3 subtype, and prostaglandin E2 receptor EP1 subtype.
Trade Name
|
Cervidil, Prepidil, Prostin E |
|---|---|
Common Name
|
dinoprostone |
ChEMBL ID
|
CHEMBL548 |
Indication
|
fetal death, gestational trophoblastic disease, uterine neoplasms |
Drug Class
|
Prostaglandins |
Image (chem structure or protein)